| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf7f3f36d20185ce15a2d1f04d5fdc1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D223-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
2004-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de7bccf70f9069e09abb39663bdaad8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1637b9342e98b40bcc10c5a541a51c10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c841e23487588f6b669c337958bb6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d179a212b5c64014859701a6b112dc7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f878b344ba1cd42835b5df008b0a4da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4edc8e6d60e76f8d35fb0a0248124831
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d99321f6e905f02e7614209bb8f9f04b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a79148a95ad1d4777b62be9e7274284 |
| publicationDate |
2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AT-529114-T |
| titleOfInvention |
TETRAHYDROBENZAZEPINE AND THEIR USE IN THE MODULATION OF DOPAMINE D3 RECEPTOR |
| priorityDate |
2003-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |